4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-16-117709
Options or other derivatives
- Chief Scientific Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Scientific Officer | 2016-05-02 | Grant or award · Restricted Stock Units | +50,000 | 50,000 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…